Baseline Lymphopenia Predicts Survival in ICI-Naïve Solid Tumor Patients Receiving Immune Checkpoint Inhibitors: A Propensity-Matched Real-World Pan-Cancer Analysis Article

sustainable development goals

publication date

  • June 14, 2026

webpage

published in

keywords

  • Immune checkpoint inhibitors
  • absolute lymphocyte count
  • healthcare utilization
  • immune-related adverse events
  • lymphopenia
  • overall survival
  • prognostic biomarker
  • real-world data
  • solid tumors

volume

  • 18

issue

  • 12